Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Fabre

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Stereotactic and Functional Neurosurgery|January 28, 2004
Deep brain stimulation for parkinson's disease: correlation between intraoperative subthalamic nucleus neurophysiology and most effective contactsP Cintas, M Simonetta-Moreau, F Ory, et al.
Annals of Neurology|June 9, 1999
ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's diseaseO Rascol, O Blin, C Thalamas, et al.
Parasitology Research|October 1, 2011
In vitro anthelmintic activity of the essential oils of Zanthoxylum zanthoxyloides and Newbouldia laevis against Strongyloides rattiP A Olounladé, E V B Azando, M S Hounzangbé-Adoté, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 2, 2001
Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's diseaseO Rascol, I Arnulf, H Peyro-Saint Paul, et al.
Archives of Neurology|February 15, 2001
Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson diseaseO Rascol, J G Nutt, O Blin, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|July 21, 2009
Neuronal in vitro models for the estimation of acute systemic toxicityA Forsby, A K Bal-Price, A Camins, et al.
British Journal of Cancer|August 14, 2003
Summary version of the Standards, Options and Recommendations for the use of analgesia for the treatment of nociceptive pain in adults with cancer (update 2002)I Krakowski, S Theobald, L Balp, et al.
Fluids and Barriers of the CNS|September 21, 2017
Abstracts from Hydrocephalus 2016A Adam, J Robison, J Lu, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Stereotactic and Functional Neurosurgery|January 28, 2004
Deep brain stimulation for parkinson's disease: correlation between intraoperative subthalamic nucleus neurophysiology and most effective contactsP Cintas, M Simonetta-Moreau, F Ory, et al.
Annals of Neurology|June 9, 1999
ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's diseaseO Rascol, O Blin, C Thalamas, et al.
Parasitology Research|October 1, 2011
In vitro anthelmintic activity of the essential oils of Zanthoxylum zanthoxyloides and Newbouldia laevis against Strongyloides rattiP A Olounladé, E V B Azando, M S Hounzangbé-Adoté, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 2, 2001
Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's diseaseO Rascol, I Arnulf, H Peyro-Saint Paul, et al.
Archives of Neurology|February 15, 2001
Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson diseaseO Rascol, J G Nutt, O Blin, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|July 21, 2009
Neuronal in vitro models for the estimation of acute systemic toxicityA Forsby, A K Bal-Price, A Camins, et al.
British Journal of Cancer|August 14, 2003
Summary version of the Standards, Options and Recommendations for the use of analgesia for the treatment of nociceptive pain in adults with cancer (update 2002)I Krakowski, S Theobald, L Balp, et al.
Fluids and Barriers of the CNS|September 21, 2017
Abstracts from Hydrocephalus 2016A Adam, J Robison, J Lu, et al.
Pageof 8